Volume 7 Supplement M May 2011

Acute myocardial infarction: long-term predictive value of thrombolysis in myocardial infarction (TIMI) and global registry of acute coronary events global registry of acute coronary events (GRACE) risk scores

• Jansen K,
• Jamart J,
• Boyasis P,
• Chenu P,
• Colles P,
• Dangoisse V,
• Domange J,
• Gabriel L,
• Guedes A,
• Marchandise B,
• Muller A,
• Paquay J,
• Perot G,
• Schroeder E

Early vs. delayed invasive strategy in patients with acute coronary syndromes without ST-segment elevation: a meta-analysis of randomised studies

• Navarese E,
• Gibson M,
• De Luca G,
• Buffon A,
• Kubica J,
• De Servi S

Acute coronary syndrome in patients with non-obstructive coronary artery disease: long-term prognosis

• Rossini R,
• Musumeci G,
• Lettieri C,
• Limbruno U,
• Molfese M,
• Capodanno D,
• Calabria P,
• Tomasi L,
• Spatari V,
• Mihalcsik L,
• Micheli A,
• Mantovani P,
• Fiocca L,
• Valsecchi O,
• Guagliumi G,
• Angiolillo D,
• Gavazzi A

Acute myocardial infarction with normal coronary arteries: a benign entity?

• Jorge C,
• Silva Marques J,
• Silva D,
• Carrilho-Ferreira P,
• Marques Da Costa J,
• Canas Da Silva P,
• Nunes Diogo A

Impact of revascularisation on longer term survival of patients presenting with troponin positive acute coronary syndrome: a real world experience

• Khan M,
• Shah N,
• Torabi A,
• Ungvari T,
• Hoye A,
• Cleland J

Tomography angiography in acute coronary syndrome: the TIACS study

• Hascoet S,
• Carrié D,
• Galinier M,
• Chabbert V,
• Rousseau H,
• Charpentier S,
• Marachet M,
• Elbaz M

Prevalence of renal insufficiency in Chinese patients who undergo coronary angiography or PCI: an observational study

• Chen Y,
• Hu S,
• Liu S,
• Zhou G,
• Zheng Y,
• Fu G

Variations in the risk of contrast induced nephropathy in patients undergoing PCI

• Jabara R,
• Chronos N,
• Manoukian S

A randomised, double-blinded comparison of Iopromide and Iodixanol in renally impaired patients undergoing cardiac catheterisation (DIRECT study)

• Chen Y,
• Hu S,
• Liu Y,
• Wang L,
• Fu G,
• He Q

Sodium bicarbonate plus N-acetylcysteine to prevent contrast induced nephropathy in the setting of primary PCI (BIcarbonato e N-Acetil-cisteina nell’infaRto mIocardico acutO, the BINARIO study)

• Leone A,
• De Caterina A,
• Sciahbasi A,
• Lioy E,
• Aurelio A,
• Basile E,
• Porto I,
• Trana C,
• Burzotta F,
• Niccoli G,
• Mazzari M,
• Mongiardo R,
• Rebuzzi A,
• Crea F

The effect of renal dysfunction on periprocedural outcome in patients undergoing elective PCI: an open-label multicentre registry

• Ntalianis A

Hypersensitive c-reactive protein and the risk of contrast induced acute kidney injury in patients undergoing PCI

• Zhou Y,
• Gao F,
• Wang Z,
• Yang S

A comparison between serum creatinine and cystatin-C for the early diagnosis of contrast induced nephropathy after coronary angiography and interventions

• Pighi M,
• Pesarini G,
• Pasoli P,
• Rigamonti A,
• Mugnolo A,
• Ribichini F,
• Vassanelli C

Serum NGAL identifies contrast nephropathy early in patients with diabetes mellitus and chronic kidney disease undergoing coronary angiography and angioplasty

• Qureshi A,
• Rampat R,
• Harwood S,
• Roughton M,
• Yaqoob M,
• Kapur A

Possible association between admission hyperglycemia and contrast medium induced nephropathy in patients undergoing primary PCI

• Fukuzawa S,
• Sugioka J,
• Okino S,
• Ikeda A,
• Maekawa J,
• Ichikawa S,
• Uchiyama T,
• Kamioka N,
• Kuroiwa N,
• Inagaki M

Preliminary results from a randomised trial on the role of Glucose-Insulin-Potassium and N-Acetyl-Cysteine for prevention of contrast induced nephropathy in high -risk patients undergoing PCI

• Campanale C,
• Nusca A,
• Contuzzi R,
• Patti G,
• D’ambrosio A,
• Mangiacapra F,
• Di Sciascio G

Invasive renal hemodynamics after left ventricular and coronary angiography with randomised use of different contrast media

• Mockel M,
• Dümichen M,
• Friedrich K,
• Kühnle Y,
• Vollert J,
• Searle J,
• Combé V,
• Schwenke C,
• Schröder M

Risk of renal dysfunction with cardiac angiography and role of N-acetylcysteine in renal protection

• Ebeid H,
• Ashour Z,
• Elkhashab K,
• Eidegwi M,
• Kandil H

Contrast induced nephropathy (CIN) in an Asian cohort from Hospital Serdang, Malaysia: an initial experience

• Lim C,
• Yusoff M,
• Abdul Ghapar A,
• Chong Y

Using benazepril before coronary intervention may not harm kidney function

• Li X,
• Li X,
• Li T,
• He L,
• Fu N,
• Cong H

Atorvastatin combining probucol can reduce the renal impairment induced with contrast-medium

• Li X,
• Li X,
• Wang Y,
• Fu N,
• Zhao R,
• Xiao J,
• Li Z,
• Cong H

The role of micro RNAs involved in the psychological stress-induced cardiac disorders in rats

• Liu B,
• Wang Y,
• Zhao Z

ADAMTS13 antigen levels are associated with increasing atherosclerotic burden in patients with stable coronary artery disease

• Peace A,
• Feys H,
• Mangiacapra F,
• Conte M,
• Muller O,
• Ntalianis A,
• Puymirat E,
• Delrue L,
• Bartunek J,
• Vanhoorelbeke K,
• Barbato E

Soluble Fms-like Tyrosine Kinase-1 (sFLT1) and its role in post-PCI myocardial infarction (Type 4a MI)

• Searle J,
• Gwosc S,
• Datwyler S,
• Holert F,
• Dechend R,
• Müller R,
• Vollert J,
• Slagman A,
• Mueller C,
• Mockel M

Preprocedural elevated white cell count and eosinophilia predict outcome in primary PCI

• Rathod K,
• Jones D,
• Guttmann O,
• Akthar M,
• Graham A,
• Sammut E,
• May S,
• Behar J,
• Jain A,
• Mathur A,
• Knight C,
• Wragg A

Early and long-term changes in serum concentration of high-sensitive C-reactive protein and fibrinogen after implantation of sirolimus-eluting coronary stents

• Provatorov S,
• Potekhina A,
• Kaznacheyeva Y,
• Masenko V,
• Osyaeva M,
• Dobrovolskiy A,
• Noyeva Y,
• Samko A

Low HDL cholesterol levels are an independent predictor of coronary artery disease in patients with aortic aneurysms

• Saigusa T

Periprocedural myocardial infarction following stent implantation: comparison between first and second generation DES

• Tandjung K,
• Basalus M,
• Muurman E,
• Louwerenburg J,
• Van Houwelingen G,
• Stoel M,
• De Man F,
• Jansen H,
• Huisman J,
• Linssen G,
• Droste H,
• Nienhuis M,
• von Birgelen C

Peri-procedural myocardial infarction after PCI for bifurcation lesions

• Song P,
• Song Y-B,
• Jang Y,
• Yoon J,
• Tahk S,
• Seung K,
• Park S,
• Gwon H-C

Insights on the mechanisms of periprocedural myocardial infarction after PCI

• Muschaert X,
• Slimani A,
• Jamart J,
• Chenu P,
• Dangoisse V,
• Gabriel L,
• Domange J,
• Guedes A,
• Marchandise B,
• Mueller A,
• Perot G,
• Schroeder E

Six-month follow-up of the prevention of cardiac and vascular periprocedural complications in patients undergoing coronary angiography or angioplasty: intracoronary Adenosine administration to prevent periprocedural myonecrosis in elective coronary angioplasty - A prospective double-blind randomised trial (PREVENT-ICARUS trial)

• Secco G,
• Iorio S,
• Venegoni L,
• Giuliani L,
• Cassetti E,
• Marino P,
• De Luca G

Routine vs. ad hoc measurement of serum creatine Kinase after PCI: a long-term prognostic comparison

• Haladyn K,
• Starmer G,
• Lim R

Spontaneous coronary artery dissection: characteristics of a large patient cohort and long-term clinical follow-up

• Paulo Guzman M,
• Lennie-Labayru V,
• Gonzalo N,
• Escaned J,
• Hernandez-Antolin R,
• Jimenez-Quevedo P,
• Bañuelos De Lucas C,
• Fernandez Ortiz A,
• Perez Viscayno M,
• Dutary J,
• Bernardo E,
• Garcia E,
• Macaya C,
• Alfonso F

Contemporary prevalence and scenarios of coronary perforation during PCI

• Del Angel Soto J,
• Del Angel Soto J,
• Perez-Vizcayno M,
• Arellano E,
• Hernandez-Antolin R,
• Ibanez B,
• Alfonso F,
• Jimenez-Quevedo P,
• Banuelos C,
• Gonzalo N,
• Macaya C,
• Escaned J

Replacement of heparin with bivalirudin does not change outcomes after coronary perforation related to PCI

• Romaguera R,
• Ben-Dor I,
• Sardi G,
• Maluenda G,
• Laynez A,
• Mahmoudi M,
• Hauville C,
• Torguson R,
• Xue Z,
• Suddath W,
• Satler L,
• Kent K,
• Pichard A,
• Waksman R

The different healing process of edge dissections after Sirolimus- and Zotarolimus-eluting stent implantation observed by optical coherence tomography

• Takeda Y,
• Tanigawa J,
• Hoshiga M,
• Ishihara T,
• Ishizaka N,
• Hanafusa T

Endothelial Nitric Oxide Synthase (eNOS) activity and vasomotor dysfunction of coronary arteries after DES: link or chance?

• Perez De Prado A,
• Perez-Martinez C,
• Cuellas C,
• Gonzalo-Orden J,
• Diego A,
• Regueiro M,
• Martinez B,
• De Miguel A,
• Ajenjo J,
• Altonaga J,
• Garcia-Iglesias M,
• Fernandez-Vazquez F

Incomplete neointimal coverage is correlated with coronary endothelial dysfunction after DES implantation

• Mitsutake Y,
• Ueno T,
• Yokoyama S

A prospective randomised comparison of vasodilation after implantation of everolimus-eluting stents and bioactive titanium-nitrid-oxide-coated stents in acute coronary syndromes: association with stent strut coverage

• Kiviniemi T,
• Ylitalo A,
• Saraste A,
• Lehtinen T,
• Biancari F,
• Mikkelsson J,
• Pietilä M,
• Airaksinen J,
• Aarnio P,
• Karjalainen P

Effects of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker on coronary endothelial function after DES implantation

• Mitsutake Y,
• Ueno T,
• Yokoyama S

Everolimus-drug eluting coronary stent Xience V non ST elevation acute coronary syndrome with coronary angioplasty in the daily practice

• Iñiguez A,
• Delcan J,
• Fernandez J,
• Oneto J,
• Rumoroso J-R,
• Castillo J,
• Albarran A,
• García E,
• Rondán J

Exploring the possible clinical impact of polymer coating in DES technology: clinical outcome of consecutive patients treated by Zotarolimus-eluting Endeavor stent and Zotarolimus-eluting Resolute stent

• Talarico G,
• Burzotta F,
• Trani C,
• Tommasino A,
• Coluccia V,
• Niccoli G,
• Porto I,
• Leone A,
• Mazzari M,
• Mongiardo R,
• Schiavoni G,
• Crea F

Head-to-head comparison of Everolimus- vs. Zotarolimus- and Sirolimus-eluting stents: one-year clinical outcomes from the ProEnCy registry

• Richardt G,
• Chevalier B,
• Tijssen J,
• Underwood P,
• Hamm C

Off label use of DES with biodegradable polymer at 2 years

• Danzi G,
• Wijns W,
• Barbato E,
• Perisic Z,
• Koning R,
• Kala P,
• Hauptmann K-E,
• Fath-Ordoubadi F,
• Carrié D,
• Chevalier B,
• Morice M-C,
• Kornowski R

Biolimus A9 drug eluting stents: comparative analyses of pharmacokinetics from three different stent platforms

• Ostojic M,
• Christians U,
• Stojkovic S,
• Beleslin B,
• Orlic D,
• Sagic D,
• Jung R,
• Clavijo C,
• Klawitter J,
• Mangovski L,
• Milosavljevic B,
• Debeljacki D,
• Paunovic D

Xience V registry - Study of Xience V Everolimus-eluting and Vision cobalt-chromium coronary stent

• Berta B,
• Nardai S,
• Barczi G,
• Becker D,
• Geller L,
• Jambrik Z,
• Molnar L,
• Ruzsa Z,
• Szabo G,
• Merkely B

Xience Nile: Prospective Multicenter Egyptian Real World Xience V stent registry

• Ragy H,
• ElKhadem M,
• El Guindy H,
• El Hossary H,
• El Etriby A,
• Khamis H,
• Khashaba A,
• Seteiha M,
• Gamal A,
• Ramsis M,
• Imam A,
• AboulMagd A,
• Abdelfattah Emam M

Biodegradable polymer coated DES registry, with 3 year follow-up

• Mimish L

Clinical evaluation of the Everolimus drug-eluting coronary stent Xience V; for the treatment of de novo coronary lesions in a real practice scenario - multicentre international SPAREX registry

• Iñiguez A,
• Delcan J,
• Sainz F,
• Fernandez J,
• Oneto J,
• Rumoroso J-R,
• Castillo J,
• Albarran A,
• García E,
• Rondan J

e-BioMatrix PMS Registry - A post market surveillance registry for the BioMatrix™ drug-eluting stent

• Urban P,
• Al-Haddad I,
• Berland J,
• Eberli F,
• Fraser D,
• Goy J,
• Hildick - Smith D,
• Iosseliani D,
• Kleber F-X,
• Oldroyd K,
• Pedrazzini G,
• Roffi M,
• Valdes M,
• Windecker S,
• Jüni P

The DIVERGE trial (DES Intervention for Treating Side Branches Effectively): 3-year clinical results

• Verheye S

Medium term clinical outcomes with everolimus-eluting stents in real world patients

• Liang M,
• Puri A,
• Hyde L,
• Devlin G

NOBORI France: comparison with Pan-European and Asian population

• Monsegu J,
• Koning R,
• Rioufol G,
• Unterseeh T,
• Carrié D,
• Darremont O,
• Tresukosol D,
• Lim V,
• Santoso T,
• Chevalier B

NOBORI 2 Study: comparative analysis of one year clinical outcome of patients treated in Asia, versus patients treated in Europe

• Tresukosol D,
• Santoso T,
• Zhang X,
• Pham M,
• Quan Huan ,
• Deng X,
• Lim V

Clinical impact of thrombus aspiration during primary PCI: results from Korea acute myocardial infarction registry

• Hachinohe D,
• Jeong M,
• Saito S,
• Hwang S,
• Lee M,
• Sim D,
• Park K,
• Kim J,
• Hong Y,
• Ahn Y

Aspiration thrombectomy during primary PCI as adjunctive therapy to early (in-ambulance) abciximab administration in patients with acute STEMI

• Ahmed T,
• Atary J,
• Wolterbeek R,
• Schalij M,
• Jukema J

Effectiveness of thrombectomy using the export aspiration catheter during primary PCI in STEMI

• Anthopoulos P,
• Alexanian I,
• Pappas L,
• Moutiris J,
• Salahas A,
• Yfantis G,
• Antonellis I,
• Karabela G,
• Flessas N,
• Michas C,
• Polydorou A

Thrombus aspiration with a tip-cut balloon angioplasty catheter may be useful in young patients with STEMI

• Iyisoy A,
• Celik M,
• Celik T,
• Bugan B,
• Yuksel U,
• Ozkan M

Combined intracoronary Tirofiban and manual thrombus extraction during primary PCI in patients with STEMI

• Natarajan D,
• Mukherjee N

Thrombectomy vs. no thrombectomy before stenting in acute myocardial infarction: an optical coherence tomographic evaluation

• Magro M,
• Guiterrez-Chico J,
• Schultz C,
• Zijlstra F,
• de Jaegere P,
• Serruys PW,
• van der Giessen WJ,
• van Geuns R-J,
• Regar E

Long-term clinical outcome of patients with coronary chronic total occlusion treated with new generation DES

• Chevalier B,
• Sagic D,
• Trani C,
• Tresukosol D,
• Laanmets P,
• Lombardi M,
• Novo Garcia E,
• Hoffmann S,
• Schwacke H,
• Birkemeyer R,
• Hildick-Smith D,
• Neskovic A,
• Stojkovic S,
• Danzi G

Clinical and procedural outcome of PCI for coronary chronic total occlusion with DES: a large single-centre experience

• Hamid T,
• Sastry S,
• Khattar R,
• Fraser D,
• El-Omar M,
• Malik N,
• Bainbridge A,
• Khalil M,
• Clarke B,
• Rees M,
• Ordoubadi F

Prognostic role of successful vs. unsuccessful revascularisation in ‘true’ coronary chronic total occlusions treated by DES

• Niccoli G,
• De Felice R,
• Fiorilli R,
• Belloni F,
• Cosentino N,
• Violini R,
• Crea F

A randomised comparison of the efficacy and safety of Zotarolimus-eluting stents vs. Sirolimus-eluting stents for PCI in coronary chronic total occlusions: the catholic total occlusion study (CATOS) trial

• Kim H,
• Park H,
• Lee J,
• Choi Y,
• Park C,
• Kim D,
• Her S,
• Kim P,
• Chang K,
• Chung W,
• Seung K

Efficacy on cardiac function in PCI for coronary chronic total occlusions analysed by echocardiography

• Takimura H,
• Muramatsu T,
• Tsukahara R,
• Ito Y,
• Sakai T,
• Ishimori H,
• Hirano K,
• Nakano M,
• Yamawaki M,
• Sasaki S,
• Araki M,
• Sakamoto Y,
• Komatsu I,
• Takama T

Successful recanalisation of chronic total occlusions is associated with increased long term survival

• Weerackody R,
• Jones D,
• Rathod K,
• Behar J,
• Kapur A,
• Jain A,
• Knight C,
• Wragg A,
• Thompson C,
• Rothman M,
• Mathur A,
• Smith E

Successful recanalisation of chronic total occlusions is associated with increased long term survival

• Weerackody R,
• Jones D,
• Rathod K,
• Behar J,
• Kapur A,
• Jain A,
• Knight C,
• Wragg A,
• Thompson C,
• Rothman M,
• Mathur A,
• Smith E

Acute stent thrombosis resulting in STEMI is associated with worse clinical outcomes than STEMI, due to native coronary thrombosis

• Pain T,
• Behar J,
• Jones D,
• Rathod K,
• Akhtar A,
• Jain A,
• Mohiddin S,
• Knight C,
• Mathur A,
• Wragg A

Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 225,536 patients and 4,203 thromboses

• D’ascenzo F,
• Biondi-Zoccai G,
• Clementi F,
• Sheiban I,
• Gaita F,
• Modena M,
• Sangiorgi G

Prevalence of hyporesponsiveness to aspirin and clopidogrel in patients with stent thrombosis: is it time for tailored therapy?

• Sambu N,
• Dent H,
• Calver A,
• Corbett S,
• Gray H,
• Simpson I,
• Curzen N

Incidence, predictors and outcome of stent thrombosis - up to 8-year follow-up in real-world patients undergoing DES implantation

• Costa R,
• Sousa A,
• Moreira A,
• Costa Jr J,
• Maldonado G,
• Cano M,
• Feres F,
• Campos C,
• Pavanello R,
• Sousa J

Evaluating the safety of very short-term dual antiplatelet therapy after Genous stent implantation: the multicentre pilot GENOUS trial

• Sangiorgi G,
• Morice M-C,
• Grinfeld L,
• Bramucci E,
• Petronio A,
• Pierli C,
• Ferlini M,
• Biondi-Zoccai G,
• Modena M,
• Colombo A

Late and very late coronary stent occlusion: intravascular ultrasound analysis of a series of consecutive patients

• Rigamonti A,
• Pesarini G,
• Dandale R,
• Ribichini F,
• Vassanelli C

Intracoronary reopro during PCI in acute and stable patient can influence stent thrombosis formation (IRPASST) study

• Balghith M,
• Alghai A,
• Ayoub K

Non-invasive evaluation of coronary flow reserve with transthoracic doppler echocardiography predicts the presence of significant stenosis in coronary arteries

• Haraldsson I,
• Gan L,
• Albertsson P,
• Matejka G,
• Omerovic E

High coronary calcium score assessed by multislice coronary computed tomography does not predict the periprocedural outcome in patients undergoing elective PCI

• Ntalianis A

Evaluation of the diagnosis accuracy of coronary computed tomographic angiography

• Pimentel WA,
• Macedo Soares M,
• Büchler J,
• Figueredo Assis S,
• Bocchi E,
• Armelin E

Complex assessment of coronary plaques using Cardio-computed tomography multislice 64 and intravascular ultrasound

• Benedek T,
• Chitu M,
• Kovacs I,
• Sarbu I,
• Suciu Z,
• Jako B,
• Benedek Jr I,
• Bucur O,
• Benedek I

Does 3-dimensional quantitative coronary angiography confer additional advantage over traditional 2-dimensional-quantitative coronary angiography in the assessment of intermediate left main coronary artery stenoses - a comparison with intravascular ultrasound?

• Porto I,
• Dato I,
• Todaro D,
• Calabrese M,
• Leone A,
• Niccoli G,
• Burzotta F,
• Rigattieri S,
• Trani C,
• Crea F

Radiation dose of 3 diagnosis tests: myocardial perfusion scintigraphy, invasive coronary angiography and cardiac computed tomography

• Sousa P,
• Gonçalves P,
• Calé R,
• Marques H,
• Santos M,
• Dias A,
• Calqueiro J,
• Ventosa A,
• Martins T,
• Silva A,
• Raposo L,
• Teles R,
• Almeida M,
• Mendes M

The impact of increased age on outcome from an early invasive strategy in patients with acute coronary syndromes: the ACACIA registry

• Malkin C,
• Chew D

Predictors of treatment in acute coronary syndromes in the elderly: impact on decision making and clinical outcome after interventional vs. conservative treatment

• Rittger H,
• Rieber J,
• Schnupp S,
• Sinha A,
• Kögler K,
• Blüm B,
• Mahnkopf C,
• Kochsiek N,
• Johannes B

In hospital mortality in the octogenarians in the primary PCI era in comparison to thrombolysis

• Egred M,
• Zaman A,
• Bagnall A,
• Purcell I,
• Ahmed J,
• Edwards R,
• Keavney B,
• Spyridopoulos I

PCI for acute coronary syndrome in elderly patients: results from a high volume centre

• Showkathali R,
• Boston-Griffiths E,
• Davies J,
• Aggarwal R

PCI outcomes in nonagenarians: data from a systematic review

• Presutti D,
• Sillano D,
• Moretti C,
• Resmini C,
• Di Cuia M,
• Omedè P,
• Sciuto F,
• Biondi-Zoccai G,
• Gaita F,
• Sheiban I

Prognosis after PCI in elderly patients

• Antonsen L,
• Jensen L,
• Thayssen P,
• Christiansen EH,
• Junker A,
• Tilsted H,
• Kaltoft A,
• Maeng M,
• Hansen K,
• Ravkilde J,
• Lassen J,
• Madsen M,
• Soerensen H,
• Thuesen L

Challenging bifurcation stenting: two-year clinical outcomes after treatment with a new generation DES

• Serra A,
• Roguin A,
• Santarelli A,
• Santoso T,
• Marzocchi A,
• Mauri Ferré F,
• Martin D,
• Karavolias G,
• Trani C,
• West N,
• Danzi G

A multicentre randomised comparison of drug-eluting balloon plus bare metal stent vs. bare metal stent vs. DES in bifurcation lesions treated with a single-stenting technique: 6-month angiographic and 12-month clinical results of the DEBIUT (Drug-Eluting Balloon In BIfUrcations Trial)

• Belkacemi A,
• Agostoni P,
• Doevendans P,
• Stella P

Final kissing balloon dilatation in simple stenting of coronary bifurcation lesions: pooled analysis of the BBC ONE study and the Nordic-Baltic bifurcation studies

• Holm N,
• Hildick-Smith D,
• Niemelä M,
• Kervinen K,
• De Belder A,
• Erglis A,
• Curzen N,
• Kumsars I,
• Oldroyd K,
• Gunnes P,
• Stables R,
• Steigen T,
• Behan M,
• Jensen L,
• überge L,
• Lassen J,
• Thuesen L

Initial results of BLAST: bifurcation lesion analysis and stenting of thin cap fibroatheroma (TCFA/FA) as measured by VH-intravascular ultrasound - a global multicentre, prospective, randomised study

• Lefèvre T,
• Erglis A,
• Gil R,
• Legutko J,
• Thomas M,
• Brunel P,
• Gilard M,
• Darremont O,
• Bøtker H,
• von Birgelen C,
• Marso S,
• Khashaba A,
• Guyon P

Improving clinical risk prediction for PCI for bifurcation lesions: the ACEF (age, creatinine, ejection fraction) score

• Sangiorgi G,
• Sheiban I,
• De Servi S,
• Tamburino C,
• Capodanno D,
• Biondi-Zoccai G,
• Romagnoli E

Long-term clinical results and predictors of adverse outcomes after 2 stents implantation for coronary bifurcation lesions in a real-world practice: the COBIS (Coronary Bifurcation Stenting) registry

• Song P,
• Song Y-B,
• Hahn J-Y,
• Choi S,
• Choi J,
• Lee S,
• Gwon H-C

Bifurcation stenting with a new generation DES: one year clinical outcome in a large cohort of patients

• Chevalier B,
• Morice M-C,
• Tresukosol D,
• Lim V,
• Santoso T,
• Zhang X,
• Pham M,
• Quan Huan D,
• Danzi G

Complete revascularisation and clinical outcomes of patients with multivessel disease

• Barbato E,
• Kornowski R,
• Wijns W,
• Unterseeh T,
• Teiger E,
• Joly P,
• Koning R,
• Lecoq G,
• Goicolea J,
• Wessely R,
• Babic R,
• Miloradovic V,
• Danzi G

Clinical risk stratification is a better determinant of long-term survival following multivessel PCI compared to anatomic risk stratification using the Syntax score

• Lehmann R,
• Spyridopoulos I,
• Leistner D,
• Laskowski R,
• Baier G,
• Kremer J,
• Held L,
• De Rosa S,
• Schaechinger V,
• Zeiher A,
• Fichtlscherer S

‘Residual’ Syntax score after PCI for triple vessel coronary artery disease: quantifying the adverse effect of incomplete revascularisation

• Malkin C,
• Ghobrial M,
• Gunn J

Percutaneous revascularisation of coronary lesions with established surgery class I indications without surgical back-up: one-year outcomes

• Del Castillo R,
• Hernando L,
• Salto M,
• Montalvo G,
• Botas J

Does a high Syntax score really predict worse outcome in PCI-treated patients with complete revascularisation strategy?

• Hamanaka I,
• Fujie H,
• Oyamada N,
• Ida M

One-year retrospective study to evaluate the outcome in patients with first time diagnosis of three-vessel coronary artery disease: implementation of the Syntax score

• Aschenbrenner T,
• Tebbe U,
• Cuneo A

Clinical impact of high sensitivity C-reactive protein on twelve-month mortality in overweight/obese patients with acute myocardial infarction undergoing PCI

• Ahmed K

Neutrophil to lymphocyte ratio predicts long-term clinical outcomes in patients with STEMI undergoing primary PCI with DES

• Yang T,
• Jin H,
• Cho Y,
• Seo J,
• Kim D,
• Kim D,
• Kim W,
• Seol S,
• Kim D,
• Kim D

Association of interleukin-10 level with increased 30-day mortality in patients with STEMI undergoing primary coronary intervention

• Youssef A,
• Yip H,
• Yang C,
• Sheu J,
• Chua S,
• Yeh K,
• Wu C-J

Clinical utility of biomarkers to predict major bleeding events after STEMI: a Horizons-AMI substudy with 3-year follow-up

• Mehran R,
• Claessen B,
• Stone G,
• Witzenbichler B,
• Brodie B,
• Ruzyllo W,
• Zmudka K,
• Giulio G,
• Wohrle J,
• Huber K,
• Kochman J,
• Apostolidou I,
• Syros G,
• Leon S,
• Dangas G

C-reactive protein as a predictor of major adverse cardiovascular events in primary PCI

• Rathod K,
• Jones D,
• Guttmann O,
• Rathod V,
• McGill L,
• May S,
• Sammut E,
• Graham A,
• Jain A,
• Mathur A,
• Knight C,
• Wragg A

Association between admission blood glucose level and in-hospital cardiovascular mortality and prognosis in patients with acute myocardial infarction

• Ardeshiri M,
• Saleh N,
• Nasiri Ahmadabadi M,
• Bakhshandeh H,
• Azizian A,
• Zandi T

Gender disparity in 7,545 consecutive patients undergoing PCI - analysis from a single university centre

• Jibran R,
• Hoye A,
• Haani N

PCI in women - clinical and angiographic differences - in-hospital results

• Cantarelli M,
• Castello H,
• Gonçalves R,
• Gioppato S,
• Ribeiro E,
• Guimarães J,
• Silva P,
• Vardi J,
• Gasperi R

Gender difference in the effect of obesity on prognosis for patients undergoing PCI

• Wang Z,
• Zhou Y,
• Zhao Y,
• Liu Y,
• Shi D

Clinical and angiographic outcomes following PCI with DES in patients of chronic kidney disease

• Takimura H,
• Muramatsu T,
• Tsukahara R,
• Itou Y,
• Sakai T,
• Ishimori H,
• Hirano K,
• Nakano M,
• Yamawaki M,
• Sasaki S,
• Araki M,
• Sakamoto Y,
• Komatsu I,
• Takama T

The increasing cohort of patients older than 85 years: challenges for interventional cardiologists

• Cabanelas N,
• Gonçalves L,
• Soares F,
• Teixeira R,
• Faria H,
• Calisto J,
• Matos V,
• Viegas R,
• Silva C,
• Queiróz M,
• Providência L

The impact of anemia on long-term clinical outcome in patients undergoing PCI

• Pilgrim T,
• Vetterli F,
• Räber L,
• Binder R,
• Wenaweser P,
• Moschovitis A,
• Khattab A,
• Büllesfeld L,
• Vogel R,
• Seiler C,
• Meier B,
• Windecker S

In-hospital and long-term outcomes of patients with STEMI with unprotected left main coronary artery stenosis undergoing primary PCI in a hospital without on-site cardiac surgery

• Tomassini F,
• Gagnor A,
• Tizzani E,
• Giolitto S,
• Giay Pron P,
• Infantino V-A,
• Rosa Brusin M,
• Varbella F

One-stage PCI of left main stenosis and infarct-related left anterior descending or circumflex arteries in STEMI patients

• Merkulov E,
• Samko A,
• Mironov V,
• Staroverov I,
• Ruda M

Treatment of multivessel coronary artery disease in primary PCI for STEMI: culprit only revascularisation is associated with higher major adverse cardiovascular event rates

• Jones D,
• Rathod K,
• Rathod V,
• Akthar M,
• Pain T,
• Jain A,
• Knight C,
• Mathur A,
• Wragg A

Acute simultaneous total occlusion of two major coronary arteries in STEMI

• Guo J,
• Xu M,
• Wang G

Is the Syntax score a predictor of early outcome in patients with cardiogenic shock complicating acute myocardial infarction?

• Abdel-Wahab M,
• Schwarz B,
• Mostafa A,
• Toelg R,
• Richardt G

Primary PCI in the presence of left bundle branch block

• Egred M,
• Lee K,
• Richardson J,
• Spyridopoulos I

Endovascular treatment of ST-segment elevation myocardial infarction with left main artery stenosis

• Merkulov E,
• Samko A,
• Mironov V,
• Ruda M

Real picture of reperfusion map with coronary angioplasty in patients with acute myocardial infarction in Spain - the RACIMO multicentre experience

• Iñiguez A,
• Cequier A,
• Sabate M,
• Valdes M,
• Vazquez N,
• Mainar V,
• Hernandez R,
• Mauri J,
• Angel J,
• Serra A

PCI and acute myocardial infarction: temporal changes in presentation, management and in-hospital mortality

• Jansen K,
• Jamart J,
• Boyazis P,
• Chenu P,
• Dangoisse V,
• Desonniaux C,
• Domange J,
• Guedes A,
• Mitri K,
• Morandini E,
• Randour C,
• Schroeder E

Analysis of subset of patients who undergo delayed primary PCI

• Crimi G,
• Bartolini D,
• Bellotti S,
• Iannone A,
• Rubartelli P

Reperfusion therapy in STEMI: do late presentation patients (≥12 hours) derive clinical benefit?

• Bainey K,
• Afzal R,
• Natarajan M

Early hospital discharge at 48 hours following primary PCI for myocardial infarction is both safe and feasible

• Sammut E,
• Jones D,
• Behar J,
• Rathod K,
• Graham A,
• Jain A,
• Knight C,
• Mohiddin S,
• Mathur A,
• Wragg A,
• Smith E

Comparative analysis of DES vs. bare metal stents for the treatment of STEMI- acute and mid-term outcomes

• Esteves V,
• Costa J,
• Costa R,
• Siqueira D,
• Abizaid A,
• Barbosa R,
• Moreira A,
• Cano M,
• Staico R,
• Maldonado G,
• Feres F,
• Sousa A,
• Sousa E

The effect of intracoronary bolus dose of abciximab administration in patients with acute ST-segment elevation myocardial infarction

• Lim S,
• Kim S,
• Ahn J,
• Song W

Effect on clinical restenosis of an ultra-thin strut cobalt chromium stent vs. a thin strut stainless steel stent

• Moretti L,
• Grossi P,
• Silenzi S,
• Volpe S,
• Clementi L,
• Lando L

Coronary angioplasty with bare metal stents: are there any differences?

• Costa F,
• Teles R,
• Gonçalves P,
• Raposo L,
• Calé R,
• Carvalho S,
• Cardoso G,
• Brito J,
• Leal S,
• Baptista J,
• Palos J,
• Almeida M,
• Mendes M

Nine-month outcomes with a second generation cobalt chromium bare metal stent in the treatment of stenotic coronary artery lesions: results from the PIONIR study

• Hoffmann S

Long-term comparison of stainless steel and cobalt-chromium bare metal stents: clinical impact of the metallic alloy in a real world scenario

• Campos C,
• Ribeiro H,
• Ybarra L,
• Spadaro A,
• Horta P,
• Perin M,
• Lemos P,
• Kajita L,
• Marchiori G,
• Ribeiro E

Clinical efficacy and safety of presillion plus cobalt chromium stents in acute coronary syndrome

• Ho H,
• Lo K,
• Ooi Y,
• Wong C,
• Foo D,
• Ong P

The Indonesia Siloam registry: titanium-nitride-oxide coated stents in real world experience

• Lukito A

Thrombosis in real practice with second generation DES in special settings: myocardial infarction and left main coronary artery - results from the ESTROFA-2 Spanish registry

• De La Torre Hernandez J,
• Alfonso F,
• Gimeno F,
• Diarte J,
• Lopez Palop R,
• Perez De Prado A,
• Fernandez-Guerrero J,
• Moreu J,
• Melgares R,
• Vazquez J,
• Rincon A,
• Cascon J,
• Serra A,
• Lozano I,
• Trillo R,
• Jimenez Mazuecos J,
• Garcia Del Blanco B,
• Pinar E,
• Sánchez-Recalde A,
• Rumoroso J-R,
• Hernandez F,
• Bosa F,
• Hernandez J,
• Larman M,
• Sanchis J,
• Rivero F,
• Diaz J,
• Elizaga J,
• Cascon M,
• Botas J,
• Gomez Jaume A,
• Salvatella N,
• Baz J,
• Bullones J

Biodegradable polymers, dual antiplatelet therapy and very late stent thrombosis: review of Nobori 2 study

• Morice M-C,
• Wijns W,
• Neskovic A,
• Goicolea F,
• Iñiguez A,
• Koning R,
• Koolen J,
• Lecoq G,
• Ostojic M,
• Teiger E,
• Unterseeh T,
• Nedeljkovic M,
• Danzi G

Impact of stent thrombosis on clinical outcomes among patients undergoing PCI with newer generation DES

• Stefanini GG,
• Kalesan B,
• Jüni P,
• Vranckx P,
• Räber L,
• Silber S,
• Serruys PW,
• Windecker S

Safety of dual antiplatelet therapy interruption after Resolute stent implantation: an Italian multicentre observational evaluation

• Tommasino A,
• Burzotta F,
• Lioy E,
• Romagnoli E,
• Ielasi A,
• Latib A,
• De Vita M,
• Ausiello A,
• Missiroli B,
• Arena M,
• Benedetto S,
• Colombo A

Clinical performance of DES with biodegradable polymeric coating, a meta-analysis and systematic review

• Ahmed T,
• Bergheanu S,
• Stijnen T,
• Plevier J,
• Quax PHA,
• Jukema J

Incidence of stent thrombosis in two large registries in Europe and Japan: a patient level data analysis from the Bern-Rotterdam and J-CYPHER registries

• Onuma Y,
• Kimura T,
• Windecker S,
• van Domburg R,
• Mitsudou K,
• Serruys PW

Incidence of definite stent thrombosis: a 2 centre experience

• Liang M,
• Puri A,
• Kong K,
• Zhang Z,
• Harding S,
• Devlin G

Clinical impact of non-high density lipoprotein cholesterol and apolipoprotein B on clinical outcomes in metabolic syndrome patients with acute myocardial infarction undergoing PCI

• Ahmed K

Impact of patient and procedural characteristics for appropriate secondary prevention therapy after PCI - Analysis from Japanese prospective multicentre registry

• Endo A,
• Kohsaka S,
• Miyata H,
• Kawamura A

Effects of low dose Pioglitazone on restenosis and atheroma plaques in patients with diabetes Mellitus undergoing PCI

• An S,
• Lee H,
• Yang M,
• An S,
• Kim J,
• Lee H,
• Cha K,
• Hong T

Effect of high-dose lipid lowering treatment compared to low-dose lipid lowering treatment with Rosuvastatin on carotid intima media thickness in high-risk patients

• Egede R,
• Jensen L,
• Hansen H,
• Antonsen L,
• Hansen K,
• Junker A,
• Thayssen P

Three-year clinical outcomes of the OLIVUS (impact of olmesartan on progression of coronary atherosclerosis; evaluation by intravascular ultrasound) trial

• Hirohata A,
• Yamamoto K,
• Hirose E,
• Ohara M,
• Senoh K,
• Imai Y,
• Iino Y,
• Kobayashi Y,
• Takafuji H,
• Sano F,
• Nosaka K,
• Ohe T

Influence of high-dose lipid lowering treatment compared to low-dose lipid lowering treatment on plaque composition assessed by intravascular ultrasound virtual histology in patients with STEMI: the VIRHISTAMI trial

• Egede R,
• Jensen L,
• Hansen H,
• Hansen K,
• Junker A,
• Thayssen P

Initial clinical and angiographic results of the Titanic XV prospective randomised trial: the Titan vs. Everolimus (Xience-V) stent in diabetic patients

• López-Mí­nguez J,
• Nogales Asensio J,
• Doncel Vecino L,
• González Fernández M,
• Merchán Herrera A,
• Martínez Cáceres G,
• Díaz Cortegana F,
• Yuste Domínguez M

Clinical evaluation of the Everolimus-drug eluting coronary stent Xience V for the treatment of de novo coronary lesions in the daily practice in diabetic patients

• Iñiguez A,
• Delcan J,
• Sainz F,
• Fernandez J,
• Oneto J,
• Rumoroso J-R,
• Castillo J,
• Albarran A,
• Rondán J

Clinical outcomes in diabetic and non-diabetic patients treated with Endeavor Resolute Zotarolimus eluting-stent: a multicentre Italian observational study

• Ielasi A,
• Latib A,
• Lioy E,
• Romagnoli E,
• Tommasino A,
• Burzotta F,
• De Vita M,
• My L,
• Missiroli B,
• Arena M,
• Della Rovere F,
• Trani C,
• Colombo A

Two-year clinical outcomes of diabetic patients treated with a new generation DES

• Wiemer M,
• Wijns W,
• Joly P,
• Kornowski R,
• Witherow F,
• Novo Garcia E,
• Apró D,
• Ates I,
• Hauptmann K-E,
• Kala P,
• Koning R,
• Danzi G

Treatment with the Resolute Zotarolimus-eluting stent in subjects with diabetes mellitus: pooled analysis from the Resolute clinical programme

• Mauri L,
• Leon M,
• Yeung A,
• Meredith I,
• Serruys PW,
• Windecker S,
• Belardi J,
• Neumann F,
• Widimsky P,
• Saito S,
• Massaro J,
• Fajadet J,
• Wijns W,
• Silber S

Major cardiovascular events after coronary Everolimus-eluting stent(s) in diabetic patients. The Middle East diabetic Xience registry

• Majwal T,
• Ahmed W

Coronary artery angiographic changes in mustard gas-intoxicated veterans

• Shabestari M,
• Gohari B,
• Moazen N,
• Ibrahimzadeh S,
• Jabari F,
• Moqiman T,
• Azizi H

Cost-effectiveness analyses of drug-eluting versus bare-metal stents

• Hwang S,
• Yin W,
• Yeh M

Retrospective analysis of the maximum exercise double product (Robinson index) during the treadmill test as an exact predictor of coronary artery disease

• Rashid H

Pooled analysis of the Resolute programme clinical safety results

• Mauri L,
• Leon M,
• Yeung A,
• Meredith I,
• Serruys PW,
• Silber S,
• Belardi J,
• Neumann F-J,
• Widimsky P,
• Saito S,
• Massaro J,
• Fajadet J,
• Wijns W,
• Windecker S

2-year follow-up of Nevo RES-elution I, a randomised multicentre comparison of the Nevo Sirolimus-eluting coronary stent system using RES technology with the Taxus Liberté Paclitaxel-eluting stent

• Fajadet J,
• Abizaid A,
• Ormiston J,
• Schofer J,
• Mauri L,
• Verheye S,
• Stoll H,
• Macours N,
• Christian S

Two-year reports of efficacy and safety end points from the randomised, multicentre and controlled Eucatax trial

• Rodriguez-Granillo A,
• Mieres J,
• Fernandez-Pereira C,
• Delacasa A,
• Vigo C,
• Risau G,
• Bernardi V,
• Bettinoti M,
• Santaera O,
• Rodríguez-Granillo G,
• Antoniucci D,
• Palacios I,
• Rodríguez A

The platinum small vessel trial: evaluation of the novel thin-strut platinum-chromium promus element small vessel everolimus-eluting stent

• Meredith I,
• Teirstein P,
• Stone G,
• Mann T,
• Rabinowitz A,
• Lee T,
• Kereiakes D,
• Carrié D,
• Cannon L,
• Allocco D,
• Dawkins K

Everolimus-eluting vs. Paclitaxel-eluting stents in PCI

• Al Azzoni A

Optimised duration of Clopidogrel therapy following treatment with the Endeavor Zotarolimus-eluting stents in the real-world clinical practice (OPTIMIZE) trial: rationale, design and preliminary blinded results of a large-scale, randomised, multicentre study

• Feres F,
• Costa R,
• Abizaid A

Five-year clinical and angiographic outcome after primary stenting of totally occluded native coronary arteries (PRISON II- Late Study): a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions

• Suttorp M

Level and value of circulating endothelial progenitor cells in patients with acute myocardial infarction undergoing primary coronary angioplasty

• Youssef A,
• Wu C,
• Hang C,
• Hsieh Y,
• Yang C,
• Cheng C,
• Chen S,
• Chua S

Randomised controlled clinical trial of the use of autologous bone marrow derived progenitor cells to salvage myocardium in patients with acute anterior myocardial infarction

• Locca D,
• Burchell T,
• Flett A,
• Yeo C,
• De Palma R,
• Knight C,
• Schwitter J,
• Rothman M,
• Martin J,
• Mathur A

G-CSF induced arteriogenesis in humans: molecular insights into a randomised controlled trial

• Meier P,
• Indermuehle A,
• Henzi B,
• Vogel R,
• Gloekler S,
• Demarchi S,
• Seiler C

Percutaneous, intra-myocardial injection of unselected bone marrow-derived mononuclear cells via NOGA-XP significantly improves ejection fraction in post-infarct patients: ALSTER STEM CELL

• Bergmann M,
• Jaquet K,
• Schneider C,
• Cuneo A,
• Krause K,
• Haller H,
• Kivelitz D,
• Kuck K-H

Clinical registry follow-up of endothelial progenitor cell capture stent in patients suffering from non ST-segment elevation acute coronary syndrome

• Amat I,
• Amado M,
• Duro I,
• Arnold R,
• Gutierrez H,
• Campo A,
• Gimeno F,
• Puerto A,
• San Roman J

Intracoronary delivery of allogeneic mesenchymal precursor cells directly after acute myocardial infarction improves cardiac function and myocardial perfusion and decreases left ventricular remodeling in sheep

• Houtgraaf J,
• De Jong R,
• Pasterkamp G,
• Serruys PW,
• Duckers H

Preclinical insights into clinical safety and delivery of vascular restoration therapy by a bioresorbable vascular scaffold

• Perkins L,
• Powers J,
• Nagarajan R,
• Follett D,
• Rapoza R,
• Virmani R

Evaluation of preclinical safety of Absorb cohort b bioresorbable vascular scaffold by employing multiple modalities

• Powers J,
• Perkins L,
• Ramesh N,
• Follett D,
• Rapoza R

Angiographic geometric changes of the lumen vessel wall after bioresorbable vascular scaffolds and metallic platform stents at one-year follow-up

• Gomez-Lara J,
• Brugaletta S,
• Farooq V,
• van Geuns R-J,
• de Bruyne B,
• Windecker S,
• McClean D,
• Thuesen L,
• Dudek D,
• Koolen J,
• Whitbourn R,
• Smits P,
• Chevalier B,
• Morel M-A,
• Dorange C,
• Veldhof S,
• Rapoza R,
• García-García HM,
• Ormiston J

Spatial distribution and temporal evolution of scattering centers by optical coherence tomography in the poly(L-lactide) backbone of a bioresorbable vascular scaffold

• Gutiérrez-Chico J-L,
• Radu M,
• Diletti R,
• Sheehy A,
• Kossuth M,
• Oberhauser J,
• Glauser T,
• Harrington J,
• Rapoza R,
• Onuma Y,
• Serruys PW

540-days follow-up of fully bioabsorbable salicylate-based Sirolimus-eluting stent evaluated by optical coherence tomography

• Jabara R,
• Chronos N,
• Matsumoto D

Comparison of novel slender 6.5 french (‘Virtual 4 French’) sheathless guiding catheter vs. 5 french guiding catheter for transradial coronary intervention

• Chiam P

Stent boost performed only with a guide wire with double distal marker as surrogate of conventional stent boost for procedural cost saving

• Landaluce C,
• Garcia-Touchard A,
• Goicolea Riugomez J,
• Fernandez Diaz J,
• Oteo J,
• Dominguez J,
• Nombela Franco L,
• Pulpon L

Plaque sealing and passivation with a mechanical self-expanding low outward force nitinol VShield device for the treatment of intravascular ultrasound and optical coherence tomography-derived thin cap fibroatheromas (TCFAS) in native coronary arteries

• Wykrzykowska J,
• Diletti R,
• Gutiérrez-Chico J-L,
• van Geuns R-J,
• van der Giessen WJ,
• Ramcharitar S,
• Duckers E,
• Schultz C,
• de Feyter P,
• Van Der Ent M,
• Regar E,
• de Jaegere P,
• García-García HM,
• Gonzalo N,
• Ligthart J,
• Serruys PW

Preliminary experience with Acrobat Svelte stent-on-a-wire system in complex coronary interventions

• Rezq A,
• Sangiorgi G

Treatment of coronary artery aneurysm with a novel covered stent

• Tondi S,
• Magnavacchi P,
• Tosoni D,
• Capelli C,
• Ricci C

Efficacy of 4F inner catheter as a distal stent delivery device

• Ashikaga T

Cholesterol levels predict the presence of coronary microvascular dysfunction

• Mangiacapra F,
• Melikian N,
• de Bruyne B,
• Peace A,
• Di Serafino L,
• Ntarladimas I,
• Bartunek J,
• Heyndrickx G,
• Wijns W,
• Barbato E

Angiographic patterns of myocardial reperfusion after primary angioplasty and ventricular remodelling

• Niccoli G,
• Cosentino N,
• Spaziani C,
• Lombardo A,
• Ferrante G,
• Montone R,
• Minelli S,
• Galiffa V,
• Fabretti A,
• Crea F

Microcirculatory function early after primary PCI is predictive of the extent of non-viable myocardium and late left ventricular function

• Ntalianis A

Head-to-head comparison of Sirolimus-eluting stent vs. bare metal stent evaluating the endothelial dysfunction in the same patient with multiple coronary artery lesions

• Mischie A,
• Nazzaro M,
• De Felice F,
• Musto C,
• Fiorilli R,
• Violini R

Incidence and predictors of microvascular dysfunction assessed by the index of microcirculatory

• Omar A

First-in-man, multicentre assessment of the novel Acrobat Svelt balloon-expandable stent-on-a-wire system

• Costa Jr J,
• Abizaid A,
• Feres F,
• Stella P,
• Fernandez A,
• Granada J,
• Sousa J,
• Serruys PW

Randomised comparison of the efficacy and safety of a novel DES with biodegradable polymer and cobalt-chromium alloy - Inspiron I trial

• Ribeiro H,
• Campos C,
• Lopes A,
• Esper R,
• Abizaid A,
• Meireles G,
• Lemos P,
• Perin M,
• Ramires J,
• Ribeiro E

Preliminary results of the multicentric, double-blinded, randomised, Vestasync II trial

• Costa Jr J,
• Abizaid A,
• Feres F,
• Oliveira B,
• Perim M,
• Costa R,
• Siqueira D,
• Staico R,
• Tanajura L

One-year follow-up of the ProNOVA XR polymer free Sirolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the EURONOVA study

• Legutko J,
• Heba G,
• Rzeszutko L,
• Zasada W,
• Jakala J,
• Dragan J,
• Klecha A,
• Giszterowicz D,
• Dobrowolski W,
• Partyka L,
• Dudek D

First-in-man experience with the DES Orsiro in the treatment of patients with single de novo coronary artery lesions (BIOFLOW-I)

• Hamon M,
• Niculescu R,
• Deleanu D,
• Waksman R,
• Weissman N

De novo coronary lesions treated with the novel polymer-free Biolimus-A9 coated stents: four- and twelve-month angiographic results from the prospective, randomised, multicentre BIOFREEDOM clinical trial

• Costa R,
• Abizaid A,
• Mehran R,
• Magalhaes M,
• Gambone L,
• Parise H,
• Schuler G,
• Hauptmann K-E,
• Schofer J,
• Grube E

Stent fracture in various DES? How does it occur?

• Kinoshita Y,
• Ito T,
• Habara M,
• Tsuchikane E,
• Katoh O,
• Suzuki T

Conformability of the Nevo; Sirolimus-eluting coronary stent system in comparison with the Xience; Everolimus-eluting coronary stent system: results from a bench top study and an angiographic assessment from the Nevo II clinical trial

• Gomez-Lara J,
• García-García HM,
• Windecker S,
• Sabate M,
• Pieters M,
• Jew V,
• Schroeder V,
• Grishaber R,
• Ryder K,
• Stoll H,
• Serruys PW

Scanning electron microscopic observation of coating irregularities and their precursors in unexpanded durable polymer-based DES

• Basalus M,
• Tandjung K,
• Grijpma D,
• Van Apeldoorn A,
• von Birgelen C

A novel approach to investigate incomplete stent apposition using virtual bench testing

• Mortier P,
• De Beule M,
• Segers P,
• Verdonck P,
• Verhegghe B

Stenting make vessel not only expanded but also shortened: Insight from stent fracture

• Oh S,
• Yang J

Vascular healing response five years after implantation of first generation DES: the SIRTAX LATE optical coherence study

• Räber L,
• García-García HM,
• Baumgartner S,
• Kalesan B,
• Justiz J,
• Pilgrim T,
• Wenaweser P,
• Moschovitis A,
• Vogel R,
• Meier B,
• Jüni P,
• Serruys PW,
• Windecker S

Optical coherence tomography assessment of early strut coverage in patients treated with the pro-kinetic Probio-coated bare cobalt-chromium stent

• Samim M,
• Agostoni P,
• Voskuil M,
• Doevendans P,
• Stella P

Tissue coverage of a hydrophilic polymer-coated Zotarolimus-eluting stent vs. a fluoropolymer-coated Everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE all-comers trial

• Gutiérrez-Chico J-L,
• van Geuns R-J,
• Regar E,
• van der Giessen WJ,
• Kelbæk H,
• Saunamäki K,
• Escaned-Barbosa J,
• Gonzalo N,
• Di Mario C,
• Borgia F,
• Nüesch E,
• García-García HM,
• Silber S,
• Windecker S,
• Serruys PW

Long-term tissue coverage of a bioresorbable polylactide polymer-coated Biolimus-eluting stent: comparative sequential assessment with optical coherence tomography till complete resorption of the polymer

• Gutiérrez-Chico J-L,
• Jüni P,
• García-García HM,
• Regar E,
• Borgia F,
• van der Giessen WJ,
• Davis S,
• van Geuns R-J,
• Secco G,
• Meis S,
• Windecker S,
• Serruys PW,
• Di Mario C

A pooled analysis of the effect of endovascular cooling on infarct size in patients with STEMI

• Erlinge D,
• Gütberg M,
• Grines C,
• Dixon S,
• Baran K,
• Olivecrona G

Drug-eluting balloon in acute myocardial infarction (DEBAMI) trial

• Wong A,
• Lim V,
• Leow K,
• Lim S,
• Wong P,
• Chiam P,
• Tan J,
• Chia S,
• Chan C,
• Lingamanaicker J,
• Koh T-H

ST-segment resolution and clinical outcome with ischemic post-conditioning - and comparison to magnetic resonance

• Lønborg J

Ischemic postconditioning can reduce the infarct size in patients with STEMI

• Watanabe T

Single-centre experience using M-Guard stent platform in primary PCI in STEMI

• Anthopoulos P,
• Alexanian I,
• Pappas L,
• Michas C,
• Moutiris J,
• Salahas A,
• Yfantis G,
• Gavaliatsis I,
• Antonellis I,
• Polydorou A

Novel use of a pericardium-covered stent (PCS) to treat massive intra-coronary thrombus

• Gunn J,
• Raina T,
• Siotia A,
• Malkin C,
• Iqbal J,
• Morton A

Factors associated with hospital mortality in acute myocardial infarction patients in percutaneous coronary intervention centre

• Tarasov R,
• Ganyukov V,
• Bohan N,
• Shushpannikov P,
• Moiseenkov G,
• Barbarash O,
• Barbarash L

Safety of Nevo Sirolimus-eluting stents with RES technology demonstrated using overlapping exagerated dose formulation stents in the porcine coronary artery model

• Price G

Multivessel coronary stenting in ST-elevation myocardial infarction without cardiogenic shock

• Tarasov R,
• Ganyukov V,
• Moiseenkov G,
• Barbarash O,
• Barbarash L

Stenting with Xience V in comparison to Endeavor Resolute and bare metal stent in an atherosclerotic rabbit double injury model

• Van Dyck C

Capture of circulatory endothelial progenitor cells and accelerated re-endothelialisation of a bioengineered stent in human ex vivo shunt and rabbit denudation model

• Larsen K,
• Cheng C,
• Tempel D,
• Parker S,
• Yazdani S,
• Ligtenberg E,
• Kolodgie F,
• Serruys PW,
• Virmani R,
• Duckers H

Anti-CD34 stent surface modification reduce thrombogenicity and increase endothelialisation

• Yazdani S,
• Parker S,
• Rowland S,
• Ligtenberg E,
• Kolodgie F,
• Virmani R

Endothelialisation of polymer-free drug coated stents

• Yazdani S,
• Su S,
• Schulze J,
• Kolodgie F,
• Virmani R

Lipostent: a liposome based gene-eluting stent resulting in enhanced re-endothelialisation in a preclinical model

• Hynes S,
• McCullagh K,
• Ganly S,
• Crowley J,
• Greiser U,
• McHugh P,
• O’ Brien T,
• Sharif F

Feasibility of a new C-arm angiography (DYNA-CT) based three-dimensional coronary reconstruction algorithm in combination with myocardial perfusion assessment

• Rittger H,
• Sinha A,
• Lauritsch G,
• Rohkohl C,
• Brachmann J,
• Rieber J

Clinical validation of a new 3-dimensional imaging system for quantitative and qualitative judgement of coronary artery stenoses

• Rittger H,
• Schertel-Grünler B,
• Sinha A,
• Mahnkopf C,
• Schnupp S,
• Kögler K,
• Brachmann J

The impact of acquisition angle differences on three-dimensional quantitative coronary angiography

• Tu S,
• Holm N,
• Koning G,
• Maeng M,
• Reiber J

Accuracy of device localisation in PCI based on the IC-PRO guidance system

• Rittger H,
• Kuper A,
• Sinha A,
• Kochsiek N,
• Brachmann J

New image processing system improves coronary artery anatomy assessment, device selection, positioning and post-deployment analysis

• Frimerman A

Percutaneous recanalisation of coronary chronic total occlusion: pre-procedural road mapping with MDCT coronary angiography (MDCT-CA)

• Malago R,
• Tavella D,
• Pezzato A,
• Alfonsi U,
• Barbiani C,
• Pozzi M,
• Benussi P

Dual-axis rotational coronary angiography is superior to conventional coronary angiography

• Lim S,
• Tan J,
• Frias F,
• Rodel G,
• Chin C,
• Ray P,
• Ng E,
• Ramond O,
• Koh T-H

The prediction of severity and risk profile of coronary artery disease assed by intravascular ultrasound and virtual histology from non-invasive examinations and genetic analysis

• Kovarnik T,
• Kral A,
• Skalicka H,
• Horak J,
• Uhrova J,
• Martasek P,
• Linhart A

Single and repeated endovascular imaging cause significant but equal acute endothelial injury of a temporary nature as opposed to stent induced injury

• van Beusekom H,
• Van Duin R,
• Krabbendam-Peters I,
• Van Haeren R,
• van der Giessen WJ

Optimal intravascular ultrasound criteria and their accuracy for defining the functional significance of intermediate coronary stenoses of different locations

• Tahk S,
• Koo B-K,
• Yang H,
• Doh J,
• Nam C,
• Lim H,
• Kim H

Absence of a relation between plaque composition in proximal non-target coronary vessels vs. cardiovascular event risk: a pilot study with volumetric radiofrequency-based intravascular ultrasound

• Huisman J,
• Hartmann M,
• Mattern E,
• Mintz G,
• Van Houwelingen G,
• Stoel M,
• De Man F,
• Linssen G,
• Pos B,
• Van Der Lee C,
• van der Palen J,
• von Birgelen C

Impact of anemia on coronary plaque components: virtual histology-intravascular ultrasound analysis

• Hong Y,
• Jeong M,
• Choi Y,
• Hwang S,
• Ko J,
• Lee M,
• Park K,
• Sim D,
• Kim J,
• Ahn Y,
• Cho JG,
• Park J,
• Kang J

Optical coherence tomography assessment of vessel trauma after stent implantation with long-term outcomes

• Bouki K,
• Sakkali E,
• Chatzopoulos D,
• Katsafados M,
• Makrygiannis I,
• Barberis D,
• Apostolou T

Vascular complications in patients undergoing transfemoral coronary angiography with and without use of vascular closure devices

• Auer J,
• Berent R,
• Primus C,
• Gurtner F,
• Vorreiter G,
• Schatzl G,
• Graheit G,
• Stock D

Randomised comparison of manual compression and use of Femoseal vascular closure device for closure after femoral artery access coronary angiography. The CLOSure dEvices Used in everyday Practice (CLOSE-UP) study

• Holm N,
• Sindberg B,
• Schou M,
• Maeng M,
• Kaltoft A,
• Bøttcher M,
• Krusell L,
• Thuesen L,
• Terkelsen C,
• Christiansen EH,
• Bøtker H,
• Kristensen S,
• Lassen J

Large single operator experience with Perclose closure device with no infection and excellent outcomes

• Kang G,
• Kang G

The effects of time, repeat access and vascular closure device use on the common femoral artery: initial results of the REPEAT study

• Turi Z,
• McEniry B,
• Mazurek A,
• Aji J,
• Hunter K,
• Milcarek B

Ultrasound-guided thrombin injection for the treatment of iatrogenic pseudoaneurysm and long-term effect

• Guo J,
• Xu M,
• Wang G

Impact of calcium distribution for successful revascularisation of coronary chronic total occlusion: assessment from computed tomography coronary angiography

• Araki M,
• Muramatsu T,
• Tsukahara R,
• Ito Y,
• Ishimori H,
• Hirano K,
• Nakano M,
• Yamawaki M,
• Sasaki S,
• Takimura H,
• Sakamoto Y,
• Komatsu I,
• Takama T

Impact of novel 0.010-inch Athlete Wizard guidewire use on successful recanalisation of coronary chronic total occlusions via antegrade access in a large single-centre registry

• Kido A,
• Ueda H,
• Natsuyama K,
• Asawa K,
• Yoshida N,
• Sasaki Y,
• Yamaguchi K,
• Kuga Y,
• Yamawaki M,
• Ueda K,
• Nishida Y

Safety and efficacy of the Rendezvous method in retrograde recanalisation for coronary chronic total occlusions

• Tanaka H,
• Kadota K,
• Hosogi S,
• Fuku Y,
• Goto T,
• Mitsudo K

Safety of retrograde recanalisations to coronary chronic total occlusion via transseptal pathways with use of a novel metal-catheter

• Takimura H,
• Muramatsu T,
• Tsukahara R,
• Ito Y,
• Sakai T,
• Ishimori H,
• Hirano K,
• Nakano M,
• Yamawaki M,
• Sasaki S,
• Araki M,
• Sakamoto Y,
• Komatsu I,
• Takama T

Well developed collateral circulation is associated with better vascular function distal to recanalised coronary chronic total occlusions

• Brugaletta S,
• Martin-Yuste V,
• Padrÿ T,
• Alvarez-Contreras L,
• Gomez-Lara J,
• García-García HM,
• Cola C,
• Liuzzo G,
• Masotti M,
• Crea F,
• Badimon L,
• Serruys PW,
• Sabate M

Coronary chronic total occlusion treatment guided by fractional flow reserve

• Sachdeva R,
• Agrawal M,
• Uretsky B

Percutaneous coronary intervention for chronic total occlusions: feasibility, safety and clinical outcomes at one year: an analysis of 190 patients

• Brandao Carreira V,
• Hakim M,
• Cohen R,
• Elhadad S

Complex coronary bifurcation lesions treated with the novel polymer-free dedicated bifurcation paclitaxel-eluting stent (Nile pax): clinical and angiographic clinical results of the prospective, multicentre bipax clinical trial

• Costa R,
• Abizaid A,
• Abizaid An,
• Garcia B,
• Berland J,
• Petrov I,
• Brenot P,
• Serruys PW,
• Royer T,
• Rubino P,
• Lasiak M,
• Fajadet J

The dedicated drug-eluting Bifurcation Optimisation Stent System (BiOSS) Registry first-in-human results

• Gil R,
• Vassilev D,
• Michalek A,
• Kulawik T,
• Kern A,
• Dobrzycki S,
• Ochala A,
• Formuszewicz R,
• Kardaszewicz P,
• Wójcik J,
• Lesiak M

Treatment of bifurcations with the dedicated Sideguard nitinol stent compared with conventional 2-stents strategies

• Foin N,
• Di Mario C,
• Jain A

Final results from the AnGIoSculpt® MuLti-Center Coronary BIfurcation STudY- AGILITY Trial

• Moses J,
• Metzger C,
• Liberman H,
• O’ Shaughnessy C,
• Douglas J,
• Turco M,
• Resar J,
• Quesada R,
• Dave R,
• Gershony G,
• Leon M

Advanced bifurcation systems mother-daughter platform, a novel system in treatment of coronary bifurcation lesions: preliminary results of the prospective, multicentre first-in-man experience

• Khorsandi M,
• Abizaid A,
• Dani S,
• Bourang H,
• Costa R,
• Kar S,
• Makkar R

Facilitated culottes in coronary artery bifurcation stenting using a dedicated side branch stent: two-year clinical outcome

• Solomon Asgedom D,
• Bjornstad P,
• Sheahan R,
• McAdam B,
• Foley D

e-Tryton Benelux Registry: 6 month follow up data on the Tryton stent in real world usage

• Scott B

Comparison of the efficacy and safety of Everolimus-, Sirolimus-, and Zotarolimus-eluting stents in patients with STEMI

• Jang J,
• Jo Y,
• Jin H,
• Seo J,
• Yang T,
• Kim D,
• Kim D,
• Kim D,
• Kim D

Sustained patency of Paclitaxel-eluting stents vs. bare metal stents 4 years after implantation in acute STEMI

• Vink M,
• Van Nooijen F,
• Laarman GJ,
• Suttorp M,
• Tijssen J,
• Slagboom T,
• Patterson M,
• Kiemeneij F,
• Amoroso G,
• Dirksen M

DES with biodegradable polymers in acute myocardial infarction

• Fath-Ordoubadi F,
• Ostojic M,
• Perisic Z,
• Koolen J,
• Mavronasiou E,
• Richardt G,
• Roguin A,
• Sagic D,
• Stabile A,
• Strupp G,
• Stojkovic S,
• Stankovic G,
• Orlic D,
• Danzi G

Comparison between Zotarolimus-eluting stents and first generation DES in the treatment of patients with acute STEMI

• Park K,
• Lim W,
• Kang S,
• Song Y,
• Hahn J-Y,
• Kang H,
• Choi Y,
• Youn T,
• Koo B-K,
• Chae I,
• Gwon H,
• Choi D,
• Kim H

One-year clinical safety and efficacy study on acute STEMI patients undergoing primary PCI using Endeavour Resolute Zotarolimus-eluting stent vs. driver bare metal stent: a single-centre study

• Tan V,
• Ong S,
• Goh Y,
• Chow J,
• Tan K,
• Lingamanaicker J,
• Chai S,
• Goh P,
• Tan C

HEBE-III randomised trial: A Zwolle sub-study with the Genous stent

• Suryapranata H,
• Ottervanger J,
• van’t Hof A,
• Hoorntje J,
• Dambrink J,
• Gosselink A,
• De Boer M

Effect of PCI with Paclitaxel-eluting stent in hemodialysis patients: comparison with Sirolimus-eluting stent

• Takimura H,
• Muramatsu T,
• Tsukahara R,
• Ito Y,
• Sakai T,
• Ishimori H,
• Hirano K,
• Nakano M,
• Yamawaki M,
• Sasaki S,
• Araki M,
• Sakamoto Y,
• Komatsu I,
• Takama T

Clinical outcomes after PCI with DES in patients with chronic kidney disease

• Takimura H,
• Muramatsu T,
• Tsukahara R,
• Ito Y,
• Sakai T,
• Ishimori H,
• Hirano K,
• Nakano M,
• Yamawaki M,
• Sasaki S,
• Araki M,
• Sakamoto Y,
• Komatsu I,
• Takama T

Small coronary vessels stenting in the DES era: very long-term (>3 years) clinical outcomes

• Quadri G,
• D’ascenzo F,
• Longo G,
• Bollati M,
• Gonella A,
• Di Cuia M,
• Omedè P,
• Moretti C,
• Sciuto F,
• Biondi-Zoccai G,
• Gaita F,
• Sheiban I

DES improve long-term outcomes compared to bare metal stents (BMS) for the treatment of isolated proximal left anterior descending (LAD) coronary artery

• Guttmann O,
• Jones D,
• Rathod K,
• Ludman A,
• Pain T,
• Akhtar M,
• Jain A,
• Knight C,
• Mathur A,
• Amersey R,
• Wragg A

Clinical benefit from drug-eluting vs. bare metal stents after rotational atherectomy for the treatment of calcified coronary lesions: results from a single-centre registry

• Mangiacapra F,
• Puymirat E,
• Peace A,
• Conte M,
• Ntarladimas I,
• Di Serafino L,
• Wijns W,
• Heyndrickx G,
• de Bruyne B,
• Barbato E

Comparison of Everolimus- vs. first generation DES In left main coronary artery lesions: the HSR-EMO experience

• Ielasi A,
• Chieffo A,
• Latib A,
• Gullace M,
• Mussardo M,
• Davidavicius G,
• Bertoldi L,
• Takagi K,
• Shannon J,
• Godino C,
• Carlino M,
• Montorfano M,
• Colombo A

Comparison of restenosis and non-resnotenosis lesions after DES Implantation for both small and diffuse lesions in diabetic patients

• Komatsu I

Zotarolimus-eluting stent implantation in acute coronary syndrome

• Tarasov R,
• Ganyukov V,
• Bohan N,
• Shilov A,
• Shushpannikov P,
• Moiseenkov G,
• Barbarash O,
• Barbarash L

Outcome of coronary interventions in octo and nanogenarians

• Liang M,
• Puri A,
• Liang J,
• Pilkington S,
• Pasupati S,
• Devlin G

Percutaneous coronary interventions for cardiac transplant vasculopathy in Chinese patients

• Tseng C,
• Yin W

DES offer limited benefit over bare metal stents inserted during vein graft PCI

• Akhtar M,
• Sammut E,
• McGill L,
• Jones D,
• Rathod K,
• Weerackody R,
• Jain A,
• Knight C,
• Mathur A,
• Wragg A

Long-term follow-up of DES vs. bare metal stents in the treatment of saphenous vein graft lesions: a single centre study

• Ybarra L,
• Pozetti A,
• Campos C,
• Ribeiro H,
• Soares P,
• Spadaro A,
• Kajita L,
• Ramires J,
• Perin M,
• Ribeiro E

Two-year clinical outcomes after treatment of saphenous vein graft with a new generation DES

• Wessely R,
• Strupp G,
• Schwacke H,
• Marzocchi A,
• Nguyen N,
• Kala P,
• Karavolias G,
• Vrolix M,
• Lanzer P,
• Jagic N,
• Wiemer M,
• Miloradovic V,
• Beleslin B,
• Stojkovic S,
• Danzi G

Comparative analysis of a distal protection system and the new stent M-Guard for the treatment of complex lesions in saphenous vein grafts

• Esteves V,
• Costa J,
• Abizaid A,
• Costa R,
• Maia F,
• Barbosa R,
• Siqueira D,
• Mattos L,
• Staico R,
• Esteves C,
• Feres F,
• Sousa A,
• Sousa E

Intravascular ultrasound predictors of no-reflow after percutaneous saphenous vein graft intervention with distal protection devices

• Hong Y,
• Mintz G,
• Jeong M,
• Ahn Y,
• Kim S,
• Lee S,
• Kim S,
• Pichard A,
• Satler L,
• Waksman R,
• Kent K,
• Suddath W,
• Hwang S,
• Ko J,
• Lee M,
• Park K,
• Sim D,
• Kim J,
• Cho J,
• Park J,
• Kang J,
• Weissman N

Long-term clinical outcomes of PCI in grafts vs. native vessels in patients with previous coronary artery bypass grafting

• Xanthopoulou I,
• Davlouros P,
• Mitropoulou G,
• Karantalis V,
• Panagiotou A,
• Tsigkas G,
• Hahalis G,
• Alexopoulos D

Paclitaxel-coated balloon in combination with bare metal stent for treatment of de novo coronary lesions: an optical coherence tomography first-in-man randomised trial balloon first vs. stent first

• Gutiérrez-Chico J-L,
• van Geuns R-J,
• Koch K,
• Koolen J,
• Duckers H,
• Regar E,
• Serruys PW

Comparison of bare metal and DES restenosis after treatment with a novel drug-eluting balloon - a subgroup analysis of the PEPPER first-in-man trial

• Toelg R,
• Richardt G,
• Wiemer M,
• Schneider H,
• Lesiak M,
• Naber C,
• Hoffman E,
• Jørgensen E,
• Kubica J,
• Dietz U,
• Hehrlein C

Trend towards lower target lesion revascularisation and measure adverse cardiovascular event rates in patients treated with drug-eluting balloon compared with DES

• Unverdorben M,
• Degenhardt R,
• Vallbracht C,
• Cremers B,
• Heuer H,
• Hengstenberg C,
• Maikowski C,
• Werner G,
• Antoni D,
• Kleber F,
• Bocksch W,
• Leschke M,
• Ackermann H,
• Boxberger M,
• Scheller B

Treatment of the coronary in-stent restenoses with Paclitaxel coated balloon catheters

• Manukov I,
• Tonev G,
• Litcanov O,
• Tcvetkovski T,
• Deenichina I,
• Marinov M,
• Goranov G,
• Aliman O,
• Manukov H,
• Milcheva E,
• Sheremetov D

3-year clinical outcome after PCI with drug-eluting balloon in small coronary vessels

• Unverdorben M,
• Degenhardt R,
• Rux S,
• Kleber F,
• Schulze-Waltrup S,
• Betge S,
• Vallbracht C,
• Boxberger M,
• Ackermann H,
• Scheller B

Predictors of recurrent restenosis after Paclitaxel-eluting balloon for the treatment of DES restenosis

• Habara S,
• Mitsudo K,
• Kadota K,
• Goto T,
• Oka N,
• Fuku Y,
• Hosogi S,
• Tanaka H,
• Tada T,
• Shigemoto Y,
• Hasegawa D,
• Otsuru S,
• Saito N

Comparison of different strategies to obtain maximal hyperaemia in the assessment of fractional flow reserve for intermediate coronary stenosis: intravenous adenosine vs. incremental dosages of intracoronary adenosine vs. intracoronary nitroprusside (Nitroprussiato vs. Adenosina nelle Stenosi Coronariche Intermedie, the NASCI study)

• Leone A,
• De Caterina A,
• Porto I,
• Niccoli G,
• Burzotta F,
• Trani C,
• Aurelio A,
• Basile E,
• Mazzari M,
• Mongiardo R,
• Rebuzzi A,
• Crea F

Development and validation of the fractional flow reserve angiographic scoring tool (FAST) to improve the angiographic grading and selection of intermediate lesions that require fractional flow reserve assessment

• Hoole S,
• Seddon M,
• Poulter R,
• Starovoytov A,
• Wood D,
• Mancini G,
• Saw J

Non-invasive computation of fractional flow reserve in patients with multivessel coronary artery disease

• Erglis A,
• Jegere S,
• Runkule Z,
• Zvaigzne L,
• Sondore D,
• Kumsars I,
• Narbute I,
• Dombrovskis A,
• Trusinskis K,
• Mintale I,
• Latkovskis G

Performance of three-dimensional vs. two-dimensional quantitative coronary angiography in discriminating functionally significant coronary stenoses according to fractional flow reserve

• Mangiacapra F,
• Conte M,
• Tu S,
• Peace A,
• Di Serafino L,
• Ntarladimas I,
• Barbato E,
• de Bruyne B,
• Reiber J,
• Wijns W

Optical coherence tomography parameters are only moderately predictive of fractional flow reserve, suggesting complimentary roles of these technologies in intermediate coronary lesion assessment

• Hoole S,
• Seddon M,
• Poulter R,
• Ooi Y,
• Wood D,
• Saw J,
• Fung A,
• Hamburger J

Defer PCI on fractional flow reserve basis: 4-year follow-up in single-centre retrospective study

• Uguccioni S,
• Uguccioni L,
• Marinucci L,
• Parisi R,
• Canestrari E,
• Battistini A,
• Del Bene R,
• Fattori S,
• Ferretti C,
• Maffei K,
• Mattioli M,
• Mazzilli L,
• Montesi P,
• Ricciardelli P

Measurement of fractional flow reserve (FFR) for guiding percutaneous coronary intervention in clinical practice

• Shaalan H

Long-term outcomes with fractional flow reserve ≥0.80

• Puri A,
• Liang M,
• Kelly D,
• Perera S,
• Menon M,
• Devlin G

Tissue coverage and neointimal hyperplasia of overlap vs. non-overlap segments in DES 9-13 months after implantation: in vivo-assessment with optical coherence tomography

• Gutiérrez-Chico J-L,
• Räber L,
• Regar E,
• Okamura T,
• Di Mario C,
• Windecker S,
• Valgimigli M,
• Sabate M,
• von Birgelen C,
• Van Es G-A,
• Serruys PW

Optical Coherence Tomography (OCT) assessment of the acute effect of high-pressure non-compliant balloon postdilation on underexpansion and malapposition in DES

• Adrianssens T,
• Ughi G,
• Onsea K,
• Kayaert P,
• Dubois C,
• Sinnaeve P,
• Coosemans M,
• Ferdinande B,
• Dhooge J,
• Desmet W

Does a last generation thin-strut DES produce a better vascular response compared with a first generation thick-strut DES?

• Ikejima H,
• Sirbu V,
• Bezerra H,
• Musumeci G,
• Lortkipanidze N,
• Fiocca L,
• Satoko T,
• Vassileva A,
• Matiashvili A,
• Valsecchi O,
• Costa M,
• Guagliumi G

Arterial repair 4 to 8 months after Zotarolimus-eluting Endeavor stent implantation: angioscopic evaluation in patients

• Ishihara T

Angioscopic assessment of arterial repair of biodegradable polymer-coated Biolimus A9-eluting stent: comparison with durable polymer-coated Sirolimus-eluting stent in patients

• Awata M,
• Fusako S,
• Ishihara T,
• Tetsuya W,
• Fujita M,
• Iida O,
• Okamoto S,
• Tanaka N,
• Dohi T,
• Mishima T,
• Mizugami Y,
• Nanto K,
• Ishida Y,
• Nanto S,
• Uematsu M,
• Nagata S

Impact of arterial injury on neointimal hyperplasia after Zotarolimus-eluting stent implantation: an IVUS study

• Collet C,
• Costa J,
• Feres F,
• Costa R,
• Siqueira D,
• Rasquin J,
• Staico R,
• Abizaid A,
• Sousa A,
• Sousa J

Stent balloon inflation duration is a critical factor for optimal stent deployment

• Mylotte D,
• Hovasse T,
• Garot P,
• Louvard Y,
• Morice M-C,
• Lefèvre T

Very small vessels (<2.5 mm) treated with Nobori DES: two-year clinical outcomes

• Carrié D,
• Karavolias G,
• Wiemer M,
• Santoso T,
• Marzocchi A,
• Laanmets P,
• West N,
• Serra A,
• Monsegu J,
• Santarelli A,
• Birkemeyer R,
• Babic R,
• Danzi G

Charlson comorbidity index as a predictor of clinical outcomes after PCI

• Urban P,
• Aptecar E,
• Darremont O,
• Ostojic M,
• Descaves C,
• Filippone V,
• Hauptmann K-E,
• Lombardi M,
• Quan Huan D,
• Tastan A,
• Vuilliomenet A,
• Zhang X,
• Sagic D,
• Danzi G

Five-year clinical outcome in patients with small vessel disease treated with drug-eluting vs. bare metal stenting

• Puymirat E,
• Mangiacapra F,
• Peace A,
• Sharif F,
• Conte M,
• Bartunek J,
• Vanderheyden M,
• Wijns W,
• de Bruyne B,
• Barbato E

Clinical impact of coronary drug eluting stents overlap

• Lim V,
• Ostojic M,
• Tresukosol D,
• Wiemer M,
• West N,
• Monsegu J,
• Barbato E,
• Unterseeh T,
• McKenzie D,
• Perisic Z,
• Danzi G

In-stent restenosis is not simply a benign clinical entity as it presents as acute coronary syndromes in 40% of cases

• Rathod K,
• Jones D,
• Rathod V,
• Akhtar M,
• Guttmann O,
• Pain T,
• Behar J,
• Jain A,
• Mathur A,
• Knight C,
• Wragg A

Repeated DES vs. balloon angioplasty for management of DES associated restenosis in de novo and in-stent restenosis lesions

• Abdelmegid M,
• Kato M,
• Ando K,
• Domei T,
• Yamaji K,
• Shirai S,
• Arita T,
• Soga Y,
• Kondo K,
• Sakai K,
• Goya M,
• Yokoi H,
• Nosaka H,
• Iwabuchi M,
• Nobuyoshi M

Serial morphological and functional assessment of in-stent restenosis

• Belkacemi A,
• Agostoni P,
• Doevendans P,
• Stella P

Long-term clinical outcome after treatment of restenotic lesions with a new generation DES

• West N,
• Sagic D,
• Ostojic M,
• Jagic N,
• Neskovic A,
• Mavronasiou E,
• Richardt G,
• Roguin A,
• Iñiguez A,
• Stabile A,
• Strupp G,
• Babic R,
• Milosavljevic B,
• Topic D,
• Danzi G

Comparison of restenosis patterns in 1st and 2nd generation DES

• Sakamoto Y,
• Muramatsu T,
• Tsukahara R,
• Ito Y,
• Ishimori H,
• Hirano K,
• Nakano M,
• Yamawaki M,
• Araki M,
• Takimura H,
• Komatsu I,
• Takama T

Stent recoil varies with DES type and influences long-term luminal loss. A comparative longitudinal study using a novel methodology for in vivo assessment of stent recoil

• Escaned J,
• Sandoval J,
• Arellano E,
• Colmenarez H,
• Gonzalo N,
• Jimenez P,
• Alfonso F,
• Fernandez Ortiz A,
• Ibanez B,
• Garcia E,
• Banuelos C,
• Hernandez R,
• Macaya C

Intravascular ultrasound findings at in-stent restenosis segment of overlapped drug-eluting stent

• Sakamoto Y,
• Muramatsu T,
• Tsukahara R,
• Ito Y,
• Ishimori H,
• Hirano K,
• Nakano M,
• Yamawaki M,
• Sasaki S,
• Araki M,
• Takimura H,
• Komatsu I,
• Takama T

Coronary atherosclerotic disease in Saudi patients: a pilot intravascular ultrasound analytical study of patients presenting with acute coronary syndrome

• Lawand S,
• Mostafa M,
• Jensen L,
• Abraham J

Is angiography enough for optimal stenting of the culprit lesion in patients with acute myocardial infarction (STEMI and NSTEMI)? An intravascular ultrasound and virtual histology (intravascular ultrasound-VH) study

• Jakala J,
• Legutko J,
• Wizimirski M,
• Rzeszutko L,
• Partyka L,
• Mrevlje B,
• Richter A,
• Margolis P,
• Kaluza G,
• Dudek D

Reproducibility of volumetric virtual histology intravascular ultrasound analyses in coronary lesions prior to stenting: an European multicentre study on between-centre reproducibility

• Huisman J,
• Egede R,
• Rdzanek A,
• Böse D,
• Erbel R,
• Kochman J,
• Okkels Jensen L,
• van der Palen J,
• Hartmann M,
• Mintz G,
• von Birgelen C

Role of intravascular ultrasound in acute myocardial infarction patients undergoing PCI

• Ahmed K

VH-intravascular ultrasound findings predict major adverse cardiovascular events, post-PCI myocardial infarction and troponin rise: the VIVA (VH-intravascular ultrasound in vulnerable atherosclerosis) study

• Calvert P,
• Obaid D,
• O’ Sullivan M,
• Shapiro L,
• McNab D,
• Densem C,
• Schofield P,
• Braganza D,
• Clarke S,
• Ray K,
• West N,
• Bennett M

Continuous neointimal hyperplasia formation after five years of different generations of DES: is there enough evidence of late ‘catch-up’?

• Collet C,
• Costa J,
• Abizaid A,
• Chamié D,
• Ricardo C,
• Staico R,
• Sanchez A,
• Feres F,
• Amanda S,
• Sousa J

Usefulness of a trans-stent fractional flow reserve gradient for assessing the results of DES implantation

• Tahk S,
• Lim H,
• Yang H,
• Yoon M,
• Jin X,
• Joe D,
• Choi S,
• Choi B,
• Park J,
• Hwang G,
• Shin J

Comparison of neointimal coverage between zotarolimus-eluting stent and everolimus-eluting stent using optical coherence tomography

• Kim J,
• Kim B,
• Ko Y,
• Choi D,
• Hong M,
• Cho Y,
• Nam C,
• Seung-Ho H,
• Choi J,
• Song Y,
• Hahn J-Y,
• Choi S,
• Kwon H,
• Jang Y

Early detection of stent tissue coverage and apposition after primary angioplasty: an optical coherence tomographic study of chromium cobaltum and first generation DES

• Prati F,
• Stazi F,
• Dutary J,
• La Manna A,
• Di Giorgio A,
• Pawlosky T,
• Gonzalo N,
• Ramazzotti V,
• Di Salvo M-E,
• Imola F,
• Tamburino C,
• Alfonso F

Mechanisms of late non-fatal stent related myocardial infarction following coronary stenting with DES and bare metal stents: insights from optical coherence tomography

• Davlouros P,
• Karantalis V,
• Mavronasiou E,
• Xanthopoulou I,
• Tsigkas G,
• Alexopoulos D

A six-month analysis of quantitative echogenicity of the second generation everolimus-eluting bioresorbable vascular scaffold in relationship with baseline greyscale intravascular ultrasound morphology of the scaffolded plaque

• Brugaletta S,
• Serruys PW,
• Ormiston J,
• Gomez-Lara J,
• Farooq V,
• van Geuns R-J,
• de Bruyne B,
• Dudek D,
• Thuesen L,
• Chevalier B,
• McClean D,
• Windecker S,
• Whitbourn R,
• Veldhof S,
• Miquel-Hebert K,
• Rapoza R,
• van Domburg R,
• Sihan K,
• de Winter S,
• García-García HM,
• Bruining N

Quantitative multi-modality imaging analysis of a fully bioresorbable scaffold: a head-to-head comparison between quantitative coronary angiography, intravascular ultrasound and optical coherence tomography

• Gutiérrez-Chico J-L,
• Serruys PW,
• Girasis C,
• Onuma Y,
• Brugaletta S,
• García-García HM,
• Regar E

Correlation of optical coherence tomography in the clinical and pre-clinical setting

• Malle C,
• Steigerwald K,
• Jehle J,
• Massberg S,
• Kastrati A,
• Schömig A,
• Joner M

Reliable assessment of stent healing in the rabbit iliac artery model by optical coherence tomography

• Steigerwald K,
• Jehle J,
• Massberg S,
• Kastrati A,
• Schömig A,
• Joner M

The use of 3-dimensional reconstruction of optical frequency domain imaging to improve our understanding of conventional PCI: the potential for clinical application

• Farooq V,
• Okamura T,
• Heo J,
• Gogas B,
• Gomez-Lara J,
• Magro M,
• Onuma Y,
• Brugaletta S,
• Radu M,
• García-García HM,
• Serruys PW

Optical coherence tomography findings of plaque rupture occurred by balloon angioplasty

• Ishimori H,
• Muramatsu T,
• Tsukahara R,
• Ito Y,
• Hirano K,
• Nakano M,
• Yamawaki M,
• Araki M,
• Sasaki S,
• Sakamoto Y,
• Takimura H,
• Komatsu I,
• Takama T

Late expansion of thin-strut self expanding stents designed for non-obstructive vulnerable plaque as imaged by intravascular ultrasound and optical coherence tomography

• van Beusekom H,
• Sorop O,
• Krabbendam-Peters I,
• Van Duin R,
• van der Giessen WJ

An automated algorithm for identification and quantification of clusters of malapposed stent struts in optical coherence tomography images

• Onsea K,
• Adrianssens T,
• Ughi G,
• Kayaert P,
• Dubois C,
• Sinnaeve P,
• Coosemans M,
• Ferdinande B,
• Dhooge J,
• Desmet W

Risk assessment for PCI of the unprotected left main coronary artery in an all-comer population

• Kayaert P,
• Desmet W,
• Sinnaeve P,
• Adrianssens T,
• Coosemans M,
• Ferdinande B,
• Onsea K,
• Dubois C

Everolimus-eluting stent implantation for unprotected left main disease: a single-centre experience

• Aranzulla T,
• De Benedictis M,
• Scrocca I,
• Meliga E,
• Conte M

Importance of medical therapy among patients with unprotected left main trunk disease who underwent PCI

• Shiba M,
• Hori M,
• Nakamura M

The value of a combination of the Syntax Score and the Euroscore for the prediction of clinical outcomes in patients after left main coronary artery stenting

• Sinning J-M,
• Stoffel V,
• Grube E,
• Nickenig G,
• Werner N

How safe and efficacious is PCI for unprotected left main stem disease in a high volume non-surgical centre?

• Fernandez J,
• Al Sahli W,
• Hobson A,
• McKenzie D,
• Wells T,
• Sinha M,
• Swallow R,
• Talwar S,
• Levy T,
• O’ Kane P

Results and predictors of long term outcomes after unprotected left main coronary artery angioplasty in octogenarians

• Rekik S,
• Brunet J,
• Hager F,
• Bayet F,
• Meille L,
• Quatre J,
• Sainsous J

Agreement between 64 multislice computed tomography and conventional coronary angiography in the follow-up of left main coronary stenting using drug eluting stents

• Ebeid H,
• Kasem H,
• Elkhashab K,
• Ghareeb S,
• Garot P,
• Lefèvre T,
• Morice M-C

Angiographic and intravascular ultrasound predictors of side branch failure during PCI with provisional side branch stenting approach in complex coronary bifurcation lesions

• Costa R,
• Feres F,
• Staico R,
• Costa Jr J,
• Siqueira D,
• Abizaid A,
• Mattos L,
• Luiz F. T,
• Sousa A,
• Sousa J,
• Colombo A

Final proximal post-dilatation to optimise results in bifurcation stenting

• Foin N,
• Secco G,
• Sayan S,
• Davies J,
• Krams R,
• Di Mario C

2 steps post-dilatation instead of kissing balloon after provisional stenting of bifurcations: insight from bench model and first in-vivo experience

• Foin N,
• Torii R,
• Mortier P,
• De Beule M,
• Viceconte N,
• Xu X,
• Krams R,
• Di Mario C

Non-compliant balloons for final kissing inflation in coronary bifurcation lesions treated with provisional T-stenting: a pilot study

• Mylotte D,
• Hovasse T,
• Lefèvre T,
• Ziani A,
• Dumonteil N,
• Louvard Y,
• Carrié D

Simultaneous kissing stents to treat left main stem bifurcation disease: real world results in 140 consecutive patients

• Gunn J,
• Siotia A,
• Malkin C,
• Raina T,
• Morton A

Early and long-term outlook of PCI for bifurcation lesions in young patients

• Sangiorgi G,
• Sheiban I,
• De Servi S,
• Tamburino C,
• Capodanno D,
• Biondi-Zoccai G,
• Romagnoli E

Drastic increase in residual platelet reactivity under clopidogrel therapy in hemodialysis patients with coronary artery disease

• Müller C,
• El Ghannudi S,
• Jesel L,
• Ohlmann P,
• Wiesel M,
• Moulin B,
• Hannedouche T,
• Gachet C,
• Morel O

Early determination of clopidogrel responsiveness by platelet-reactivity-index identifies patients at risk for cardiovascular events after myocardial infarction

• Schäfer A,
• Flierl U,
• Seydelmann N,
• Bauersachs J

Evaluation of feasible timing of elective non-cardiac procedure after antiplatelet discontinuation in patients previously underwent PCI

• Cho J,
• Ahn B,
• Yoo H,
• Kim J,
• Jung D,
• Choi S,
• Park M,
• Lee N

High residual platelet reactivity after clopidogrel loading and long-term thrombotic events in patients with acute coronary syndrome undergoing invasive treatment: the RECLOSE-ACS trial

• Antoniucci D,
• Parodi G,
• Valenti R,
• Marcucci R,
• Giusti B,
• Migliorini A,
• Buonamici P,
• Abbate R

Clopidogrel loading dose adjustment according to platelet reactivity monitoring in patients carrying of the 2C19 2* loss of function polymorphism

• Omar A

Lack of correlation between platelet reactivity and glycaemic control in type 2 diabetes mellitus patients treated with aspirin and clopidogrel

• Mangiacapra F,
• Peace A,
• Di Serafino L,
• Ntarladimas I,
• Wijns W,
• Barbato E

Effect of high loading dose of clopidogrel vs glycoprotein llb/llla receptor antagonist in management of patients with non-st-segment elevation acute coronary syndrome

• Hamza M

The impact of glycemic control on platelet reactivity in type II diabetes mellitus

• Mylotte D,
• Kavanagh G,
• Peace A,
• Tedesco A,
• Carmody D,
• O’ Reilly M,
• Foley D,
• Smith D,
• Kenny D

Clinical efficacy of loading-dose sarpogrelate HCl on top of dual antiplatelet pretreatments in patients with acute ST-elevation myocardial infarction (STEMI) before primary percutaneous coronary intervention (PCI)

• Cho J,
• Ahn B,
• Hana Y,
• Shin Y,
• Rha D,
• Jung C,
• Jung S,
• Choi S,
• Lee N

Effect of shorter dual antiplatelet therapy after implantation of new generation drug eluting stent

• Morice M-C,
• Monsegu J,
• Tresukosol D,
• Lim V,
• Santoso T,
• Zhang X,
• Manh Hung P,
• Ostojic M,
• West N,
• Danzi G

Clinical impact of short term discontinuation of dual antiplatelet therapy (DAPT) after drug eluting stent (DES) implantation for coronary artery disease

• Sakamoto Y,
• Muramatsu T,
• Tsukahara R,
• Ito Y,
• Ishimori H,
• Hirano K,
• Nakano M,
• Yamawaki M,
• Sasaki S,
• Motoharu A,
• Takimura H,
• Komatsu I,
• Takama T

Impact of thrombus aspiration on myocardial perfusion and left ventricle function in patients with anterior STEMI treated with primary angioplasty

• Lelek M,
• Wita K,
• Drzewiecki J,
• Trusz-Gluza M

Predictors of short-term mortality in patients with STEMI undergoing primary percutaneous transluminal coronary angioplasty

• Pyxaras S,
• Cinquetti M,
• Perkan A,
• Barbati G,
• Vitrella G,
• Santangelo S,
• Giannini F,
• Rakar S,
• DellaGrazia E,
• Salvi A,
• Sinagra G

Impact of thrombus aspiration on plasma levels of platelet-derived growth factor in patients with STEMI

• Koizumi T,
• Komiyama N

Non-obstructive coronary disease leading to STEMI: assessment of residual stenosis after thrombus aspiration

• Brito J,
• Gonçalves P,
• Raposo L,
• Teles R,
• Calé R,
• Sousa P,
• Galvïo Santos P,
• Santos M,
• Batista J,
• Palos J,
• Sousa Almeida M,
• Mendes M

Impact of PercuSurge guidewire device on prevention and reduction of recovery time from complete heart block in patients with acute inferior myocardial infarction undergoing primary PCI

• Youssef A,
• Chiu C,
• Wu C-J,
• Hsieh Y,
• Yang C,
• Chen S,
• Chen C,
• Cheng C

Rheolytic thrombectomy for acute coronary thrombotic occlusion of left main in patients with acute myocardial infarction complicated by cardiogenic shock

• Migliorini A,
• Valenti R,
• Parodi G,
• Vergara R,
• Carrabba N,
• Cerisano G,
• Buonamici P,
• Antoniucci D

Thrombus burden guided treatment strategies in primary PCI

• Hore D,
• Pannala L,
• Rao V

Safety and efficacy of transradial vs. transfemoral arterial primary coronary angioplasty for acute myocardial infarction single-centre experience

• Youssef A,
• Yip H,
• Chung S,
• Wu C-J,
• Chen S,
• Hang C